tradingkey.logo

Harvard Bioscience Inc

HBIO
0.753USD
-0.014-1.79%
收盘 12/19, 16:00美东报价延迟15分钟
33.59M总市值
亏损市盈率 TTM

Harvard Bioscience Inc

0.753
-0.014-1.79%

关于 Harvard Bioscience Inc 公司

Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.

Harvard Bioscience Inc简介

公司代码HBIO
公司名称Harvard Bioscience Inc
上市日期Oct 21, 2013
CEODuke (John D)
员工数量330
证券类型Ordinary Share
年结日Oct 21
公司地址84 October Hill Rd
城市HOLLISTON
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编01746-1371
电话15088938999
网址https://www.harvardbioscience.com/
公司代码HBIO
上市日期Oct 21, 2013
CEODuke (John D)

Harvard Bioscience Inc公司高管

名称
名称/职务
职务
持股
持股变动
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
421.13K
+35.36%
Mr. Stephen J. DeNelsky
Mr. Stephen J. DeNelsky
Director
Director
110.00K
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
87.29K
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Robert Benson
Mr. Robert Benson
Independent Director
Independent Director
--
--
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--
Mr. Mark Frost
Mr. Mark Frost
Interim Chief Financial Officer, Treasurer
Interim Chief Financial Officer, Treasurer
--
--
名称
名称/职务
职务
持股
持股变动
Ms. Katherine Anne Eade, J.D.
Ms. Katherine Anne Eade, J.D.
Lead Independent Director
Lead Independent Director
421.13K
+35.36%
Mr. Stephen J. DeNelsky
Mr. Stephen J. DeNelsky
Director
Director
110.00K
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
87.29K
--
Mr. John D. Duke
Mr. John D. Duke
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Robert Benson
Mr. Robert Benson
Independent Director
Independent Director
--
--
Mr. Sandy Martin
Mr. Sandy Martin
Investor Relations
Investor Relations
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Instruments, equipment, software and accessories
18.18M
88.89%
Service, maintenance and warranty contracts
2.27M
11.11%
地区USD
名称
营收
占比
United States
9.66M
47.22%
Europe, Middle East and Africa
6.59M
32.22%
China
2.45M
11.99%
Rest of Asia
1.33M
6.52%
Americas - Other
422.00K
2.06%
业务
地区
业务USD
名称
营收
占比
Instruments, equipment, software and accessories
18.18M
88.89%
Service, maintenance and warranty contracts
2.27M
11.11%

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
AMH Equity, Ltd.
7.51%
Weber Capital Management, LLC
7.18%
Harvey Partners, LLC
4.60%
The Vanguard Group, Inc.
4.15%
Green (James W)
3.67%
其他
72.88%
持股股东
持股股东
占比
AMH Equity, Ltd.
7.51%
Weber Capital Management, LLC
7.18%
Harvey Partners, LLC
4.60%
The Vanguard Group, Inc.
4.15%
Green (James W)
3.67%
其他
72.88%
股东类型
持股股东
占比
Hedge Fund
17.67%
Investment Advisor
11.36%
Individual Investor
10.50%
Investment Advisor/Hedge Fund
10.39%
Venture Capital
7.18%
Pension Fund
2.04%
Research Firm
0.15%
Family Office
0.07%
Bank and Trust
0.01%
其他
40.63%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
201
25.97M
58.27%
-8.70M
2025Q2
214
34.64M
78.35%
-7.01M
2025Q1
216
35.57M
80.46%
-4.66M
2024Q4
216
39.38M
90.28%
+2.67M
2024Q3
217
37.20M
85.38%
-773.14K
2024Q2
216
36.12M
83.22%
-2.57M
2024Q1
216
36.60M
84.34%
-2.39M
2023Q4
219
36.53M
85.65%
-2.57M
2023Q3
223
36.90M
86.54%
-1.23M
2023Q2
223
36.47M
86.49%
-881.53K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
AMH Equity, Ltd.
4.05M
9.09%
+538.83K
+15.36%
Aug 06, 2025
Weber Capital Management, LLC
3.20M
7.19%
+683.45K
+27.15%
Mar 31, 2025
Harvey Partners, LLC
2.14M
4.81%
-46.40K
-2.12%
Jun 30, 2025
The Vanguard Group, Inc.
1.85M
4.16%
-284.86K
-13.32%
Jun 30, 2025
Green (James W)
1.64M
3.68%
-392.52K
-19.34%
Aug 15, 2025
272 Capital LLC
1.56M
3.49%
+1.56M
--
Sep 30, 2024
Acadian Asset Management LLC
1.04M
2.33%
-37.84K
-3.51%
Jun 30, 2025
Duke (John D.)
1.00M
2.25%
+1.00M
--
Aug 08, 2025
Meros Investment Management, LP
919.95K
2.07%
+125.27K
+15.76%
Jun 30, 2025
Florida State Board of Administration
910.00K
2.04%
+130.66K
+16.77%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Franklin US Small Cap Multifactor Index ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
Lattice Hartford Multifactor Small Cap ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
ProShares Hedge Replication ETF
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Proshares Ultra Russell 2000
0%
查看更多
Franklin US Small Cap Multifactor Index ETF
占比0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0%
Lattice Hartford Multifactor Small Cap ETF
占比0%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0%
ProShares Hedge Replication ETF
占比0%
ProShares UltraPro Russell2000
占比0%
iShares Russell 2000 Growth ETF
占比0%
iShares Russell 2000 ETF
占比0%
DFA Dimensional US Sustainability Core 1 ETF
占比0%
Proshares Ultra Russell 2000
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Harvard Bioscience Inc的前五大股东是谁?

Harvard Bioscience Inc 的前五大股东如下:
AMH Equity, Ltd.持有股份:4.05M,占总股份比例:9.09%。
Weber Capital Management, LLC持有股份:3.20M,占总股份比例:7.19%。
Harvey Partners, LLC持有股份:2.14M,占总股份比例:4.81%。
The Vanguard Group, Inc.持有股份:1.85M,占总股份比例:4.16%。
Green (James W)持有股份:1.64M,占总股份比例:3.68%。

Harvard Bioscience Inc的前三大股东类型是什么?

Harvard Bioscience Inc 的前三大股东类型分别是:
AMH Equity, Ltd.
Weber Capital Management, LLC
Harvey Partners, LLC

有多少机构持有Harvard Bioscience Inc(HBIO)的股份?

截至2025Q3,共有201家机构持有Harvard Bioscience Inc的股份,合计持有的股份价值约为25.97M,占公司总股份的58.27%。与2025Q2相比,机构持股有所增加,增幅为-20.08%。

哪个业务部门对Harvard Bioscience Inc的收入贡献最大?

在FY2025Q2,Instruments, equipment, software and accessories业务部门对Harvard Bioscience Inc的收入贡献最大,创收18.18M,占总收入的88.89%。
KeyAI